Device Neuro Pain (Includes Interventional)

Accurian

Payments companies reported to CMS as associated with Accurian. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$127Kassociated payments (2023-2025)
1,315clinicians with associated payments
1company reporting

By year

2023 $54K
2024 $38K
2025 $35K

Payments reported as associated with Accurian, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine (Anesthesiology) $28K
Interventional Pain Medicine $17K
Pain Medicine (Physical Medicine & Rehabilitation) $13K
Physical Medicine & Rehabilitation $12K
Anesthesiology $10K
Physician Assistant $5,981

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Accurian

These are the largest totals companies reported as associated with Accurian. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Aileen Padilla Perrysburg, OH Physical Medicine & Rehabilitation $5,941.03
Jack Smith Williamsport, PA Pain Medicine (Physical Medicine & Rehabilitation) $5,446.88
Richard Stayner Edina, MN Pain Medicine (Anesthesiology) $4,500.00
Daniel Kendall Mc Lean, VA Pain Medicine (Anesthesiology) $2,522.08
Jonathan Grossman Visalia, CA Interventional Pain Medicine $2,504.62
Carlos Untal San Luis Obispo, CA Pain Medicine (Anesthesiology) $2,503.84
Timothy Kuang San Luis Obispo, CA Pain Medicine (Physical Medicine & Rehabilitation) $2,082.03
Joseph Cabaret Camarillo, CA Interventional Pain Medicine $1,610.05
Jashvant Patel San Luis Obispo, CA $1,492.78
Boris Pilch San Luis Obispo, CA $1,457.73

Prescribed Accurian?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.